Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Q Huang

Showing results (21-30 of 221) with videos related to

Pageof 23
Sort By:
Seminars in Liver Disease|August 25, 2022
Shared Mechanisms between Cardiovascular Disease and NAFLDDaniel Q Huang, Michael Downes, Ronald M Evans, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2024
The Global Burden of Alcohol-associated Cirrhosis and Cancer in Young and Middle-aged AdultsPojsakorn Danpanichkul, Cheng Han Ng, Darren Jun Hao Tan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2022
Renal Outcomes With Tenofovir Alafenamide in Liver Transplant RecipientsJoanne K Liu, Philip Vutien, Daniel Q Huang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 13, 2023
Racial and Ethnic Disparities in Characteristics and Care Patterns of Chronic Hepatitis B Patients in the United StatesJoanne K Liu, Leslie Y Kam, Daniel Q Huang, et al.
Hepatology International|December 11, 2023
Incidence and predictors of hepatocellular carcinoma in NAFLD without diagnosed cirrhosis: a nationwide real-world U.S. studyDaniel Q Huang, Sally Tran, Scott Barnett, et al.
Cell Metabolism|July 12, 2023
Response to Paik et al. on the disease burden of NAFLDNicholas W S Chew, Cheng Han Ng, Darren J H Tan, et al.
Alimentary Pharmacology & Therapeutics|February 6, 2026
Network Meta-Analysis: Comparison of Pharmacological Therapies in Compensated Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis for Fibrosis Regression and MASH ResolutionMatheus Souza, Lubna Al-Sharif, Vanio L J Antunes, et al.
Nature Reviews. Gastroenterology & Hepatology|March 28, 2023
Global epidemiology of cirrhosis - aetiology, trends and predictionsDaniel Q Huang, Norah A Terrault, Frank Tacke, et al.
Cardiovascular Diabetology|November 28, 2025
Plasma inflammatory proteome profiles identify MASLD among children with overweight or obesityYouxin Wang, Daniel Q Huang, Pingping Zhang, et al.
Cell Metabolism|July 6, 2022
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancerDaniel Q Huang, Amit G Singal, Yuko Kono, et al.
Pageof 23

Showing results (21-30 of 221) with videos related to

Sort By:
Pageof 23
Seminars in Liver Disease|August 25, 2022
Shared Mechanisms between Cardiovascular Disease and NAFLDDaniel Q Huang, Michael Downes, Ronald M Evans, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 1, 2024
The Global Burden of Alcohol-associated Cirrhosis and Cancer in Young and Middle-aged AdultsPojsakorn Danpanichkul, Cheng Han Ng, Darren Jun Hao Tan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 5, 2022
Renal Outcomes With Tenofovir Alafenamide in Liver Transplant RecipientsJoanne K Liu, Philip Vutien, Daniel Q Huang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 13, 2023
Racial and Ethnic Disparities in Characteristics and Care Patterns of Chronic Hepatitis B Patients in the United StatesJoanne K Liu, Leslie Y Kam, Daniel Q Huang, et al.
Hepatology International|December 11, 2023
Incidence and predictors of hepatocellular carcinoma in NAFLD without diagnosed cirrhosis: a nationwide real-world U.S. studyDaniel Q Huang, Sally Tran, Scott Barnett, et al.
Cell Metabolism|July 12, 2023
Response to Paik et al. on the disease burden of NAFLDNicholas W S Chew, Cheng Han Ng, Darren J H Tan, et al.
Alimentary Pharmacology & Therapeutics|February 6, 2026
Network Meta-Analysis: Comparison of Pharmacological Therapies in Compensated Metabolic Dysfunction-Associated Steatohepatitis Cirrhosis for Fibrosis Regression and MASH ResolutionMatheus Souza, Lubna Al-Sharif, Vanio L J Antunes, et al.
Nature Reviews. Gastroenterology & Hepatology|March 28, 2023
Global epidemiology of cirrhosis - aetiology, trends and predictionsDaniel Q Huang, Norah A Terrault, Frank Tacke, et al.
Cardiovascular Diabetology|November 28, 2025
Plasma inflammatory proteome profiles identify MASLD among children with overweight or obesityYouxin Wang, Daniel Q Huang, Pingping Zhang, et al.
Cell Metabolism|July 6, 2022
Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancerDaniel Q Huang, Amit G Singal, Yuko Kono, et al.
Pageof 23